On November 15, 2021 Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, reported that John P. Butler, Chief Executive Officer, will present at the Jefferies London Healthcare Conference, which takes place November 16 – 19, 2021 (Press release, Akebia, NOV 15, 2021, View Source/news-releases/news-release-details/akebia-therapeutics-present-jefferies-london-healthcare" target="_blank" title="View Source/news-releases/news-release-details/akebia-therapeutics-present-jefferies-london-healthcare" rel="nofollow">View Source [SID1234595634]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The on-demand presentation will be available beginning at 8:00 a.m. GMT on November 18 through the conference site. The webcast will also be available through the Investors section of the Company’s website at View Source for approximately 30 days following the conference.